33,918 results match your criteria Chest[Journal]


Acute Lobar Atelectasis.

Authors:
John J Marini

Chest 2018 Dec 5. Epub 2018 Dec 5.

Pulmonary & Critical Care Medicine Divisions, Regions Hospital & University of Minnesota, Minneapolis/ St. Paul MN, USA. Electronic address:

Lobar atelectasis (or collapse) is an exceedingly common, rather predictable and potentially pathogenic companion to many forms of acute illness, post-operative care, and chronic debility. Readily diagnosed by routine chest imaging and bedside ultrasound, the consequences from lobar collapse may be minor or serious, depending on extent, mechanism, patient vulnerability, abruptness of onset, effectiveness of hypoxic vasoconstriction and compensatory reserves. Measures taken to reduce secretion burden, assure adequate secretion clearance, maintain upright positioning, reverse lung compression and sustain lung expansion accord with a logical physiologic rationale. Read More

View Article
December 2018
1 Read

A 57-Year-Old Man With Subacute Progressive Hemoptysis and Fevers.

Chest 2018 Dec;154(6):e181-e185

Department of Medicine, The University of Texas Southwestern Medical Center, Dallas, TX. Electronic address:

Case Presentation: A 57-year-old man was admitted for 1 month of accelerating hemoptysis and hematemesis. Two weeks earlier, he first presented with fevers and hemoptysis of 2 weeks' duration and was diagnosed with community-acquired pneumonia treated with 5 days of ceftriaxone and azithromycin. He improved and was discharged, but his hemoptysis recurred 1 day after discharge and progressed over 9 days, leading to the present admission. Read More

View Article
December 2018
1 Read

A 44-Year-Old Woman With Sudden Breathlessness, Tightness in Chest, and Hypotension After Extubation in the Early Postoperative Period After Liver Transplantation.

Chest 2018 Dec;154(6):e177-e180

Critical Care Medicine Department, Instituto Nacional de Ciencias Médicas y Nutricion Salvador Zubiran, Mexico City, Mexico. Electronic address:

Case Presentation: A 44-year-old woman with Child-Pugh class C cirrhosis due to primary biliary cirrhosis and mild portopulmonary syndrome received a liver transplant. Her basal catheterization showed a mean pulmonary arterial pressure (mPAP) of 28 mm Hg, pulmonary artery occlusion pressure (PAOP) of 8 mm Hg, pulmonary vascular resistance (PVR) of 307 dynes.s. Read More

View Article
December 2018

A 56-Year-Old Man With Cardiac Tamponade and Eosinophilia.

Chest 2018 Dec;154(6):e173-e176

Département de Médecine Interne, Université Paris-Diderot, Assistance Publique Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Paris, France; Unite INSERM U1149, Paris, France. Electronic address:

Case Presentation: A 56-year-old man was admitted to the ICU with chest pain, cough, hemoptysis, increasing dyspnea, and orthopnea for 1 week. The patient reported an 8-kg weight loss over the last month and recurrent wheezing episodes for approximately 1 year. He had a history of tobacco smoking and excessive alcohol consumption, both of which he stopped 15 years ago. Read More

View Article
December 2018

A 33-Year-Old Woman With Altered Mental Status and Elevated Ammonia Level.

Chest 2018 Dec;154(6):e169-e171

Department of Medicine, Division of Pulmonary Critical Care and Sleep Disorders Medicine, University of Louisville, Louisville, KY.

Case Presentation: A 33-year-old woman was brought to the ED with altered mental status. She was combative on presentation but spontaneously progressed into a comatose state and was intubated for airway protection. Naloxone failed to improve her mental status. Read More

View Article
December 2018

A 6-Month-Old Infant Admitted for Endoscopy With Acute Cardiorespiratory Decompensation.

Chest 2018 Dec;154(6):e165-e167

Cohen Children's Medical Center of NY, New Hyde Park, NY. Electronic address:

View Article
December 2018
1 Read

A Patient With Chest Pain and Hyperacute T Waves.

Chest 2018 Dec;154(6):e161-e164

Department of Cardiology, Fundación Valle del Lili, Cali, Colombia.

View Article
December 2018

A Patient in Respiratory Distress After Esophagectomy.

Chest 2018 Dec;154(6):e157-e160

Critical Care Medicine Service, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article
December 2018

A Man in His 50s Presenting With Rapid-Onset Dyspnea and Obstructive Shock.

Chest 2018 Dec;154(6):e153-e156

Legacy Good Samaritan Medical Center, Graduate Medical Education - Internal Medicine, Portland, OR.

View Article
December 2018

Response.

Chest 2018 Dec;154(6):1464

Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Electronic address:

View Article
December 2018

Electromagnetic Navigation-Guided One-Stage Dual Localization of Small Pulmonary Nodules.

Chest 2018 Dec;154(6):1462-1463

Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital and School of Medicine, National Yang-Ming University, Taipei, Taiwan.

View Article
December 2018

Response.

Chest 2018 Dec;154(6):1462

Department of Medicine, University of Chicago, Chicago, IL; Center for Healthcare Delivery Science and Innovation, University of Chicago, Chicago, IL. Electronic address:

View Article
December 2018

Lactate Measurements: A Guide to Therapy or to Quality?

Chest 2018 Dec;154(6):1461

Department of Intensive Care, Pontificia Universidad Católica de Chile, Santiago, Chile.

View Article
December 2018

Clinical Issues in Severe Asthma: Debates and Discussions About Personalizing Patient Management.

Chest 2018 Dec;154(6):1459-1460

University of Pittsburgh Asthma Institute at UPMC/UPSOM, Department of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.

An outsized proportion of asthma-related morbidity and mortality is borne by the 5% to 15% of affected patients who have severe forms of the disease. These patients experience poorly controlled symptoms and frequent exacerbations despite daily treatment with high-dose inhaled corticosteroids and other long-acting controller medications. Ongoing research has elucidated key pathophysiologic processes and other clinical parameters related to asthma severity and persistence. Read More

View Article
December 2018

Life Force.

Authors:
Marilee Richards

Chest 2018 Dec;154(6):1458

Sedona, AZ.

View Article
December 2018

Is This Now the Time for Faith?

Chest 2018 Dec;154(6):1457

Springfield, MA.

View Article
December 2018

Death, Now or Later.

Chest 2018 Dec;154(6):1456

Springfield, MA.

View Article
December 2018

Landscapes.

Authors:
Diane Conmy

Chest 2018 Dec;154(6):1455

Oak Park, IL.

View Article
December 2018

Idiopathic Pulmonary Fibrosis: Prospective, Case-Controlled Study of Natural History and Circulating Biomarkers.

Chest 2018 Dec;154(6):1359-1370

Immunology and Inflammation Therapeutic Area, Sanofi R&D, Paris, France.

Background: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with 3 to 5 years' survival. Although FVC is used to assess disease progression and treatment response, identifying predictive circulating blood biomarkers could help identify specific biologic pathways for treatment. An international, prospective, noninterventional, case-controlled, 52-week study was therefore conducted to identify a clinical and biomarker baseline profile predictive of longitudinal disease behavior. Read More

View Article
December 2018

Rebuttal From Dr Han.

Authors:
MeiLan K Han

Chest 2018 Dec;154(6):1282-1283

Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI. Electronic address:

View Article
December 2018

Rebuttal From Dr Washko.

Authors:
George R Washko

Chest 2018 Dec;154(6):1281-1282

Lung Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA. Electronic address:

View Article
December 2018

COUNTERPOINT: Should Chest CT Be Part of Routine Clinical Care for COPD? No.

Authors:
MeiLan K Han

Chest 2018 Dec;154(6):1278-1281

Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI. Electronic address:

View Article
December 2018

POINT: Should Chest CT Be Part of Routine Clinical Care for COPD? Yes.

Authors:
George R Washko

Chest 2018 Dec;154(6):1276-1278

Lung Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA. Electronic address:

View Article
December 2018

Giants in Chest Medicine: Gerard M. Turino, MD.

Authors:
Jerome Cantor

Chest 2018 Dec;154(6):1274-1275

Department of Pharmaceutical and Allied Health Sciences, St John's University, Queens, NY. Electronic address:

View Article
December 2018

New Insights Into the Epidemiology of Bronchiectasis.

Authors:
James D Chalmers

Chest 2018 Dec;154(6):1272-1273

Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, Scotland. Electronic address:

View Article
December 2018

Asthma/COPD Overlap: A Gene by Environment Interaction?

Chest 2018 Dec;154(6):1270-1271

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Colege of Medicine, Tucson, University of Arizona Health Sciences, Tucson, AZ. Electronic address:

View Article
December 2018

From Early Goal-Directed Therapy to Late(r) Scvo Checks.

Chest 2018 Dec;154(6):1267-1269

Department of Intensive Care, CHIREC Hospitals, Université Libre de Bruxelles, Brussels, Belgium.

View Article
December 2018

Principled Lung Cancer Screening Follows Screening Principles.

Chest 2018 Dec;154(6):1265-1266

Oncimmune USA, LLC, Napa, CA.

View Article
December 2018

A Review of Sleep-Related Violence: The Demographics of Sleep Forensics Referrals to a Single Center.

Chest 2018 Nov 22. Epub 2018 Nov 22.

Department of Neurology, University of MN Medical School (retired).

This review of Sleep-Related Violence reports the nature of the underlying sleep-suspected conditions encountered and helps establish the spectrum of sleep-related behaviors resulting in forensic consequences. This information may begin to bridge the gap between the differing medical and legal concepts of automatisms (complex motor behaviors occurring in the absence of conscious awareness and therefore without culpability). Increasingly, sleep medicine professionals are asked by legal professionals whether a sleep-related condition could possibly have played a role in a forensic-related event. Read More

View Article
November 2018
2 Reads

Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis.

Chest 2018 Nov 22. Epub 2018 Nov 22.

Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.

Background: Declines in percent predicted forced vital capacity (% predicted FVC), declines in 6-minute walk distance (6MWD), and respiratory hospitalizations are events associated with disease progression and mortality in idiopathic pulmonary fibrosis (IPF). The incidence of multiple events in the same patient over 12 months of pirfenidone treatment is unknown.

Methods: Patients who received pirfenidone 2403 mg/day (n = 623) or placebo (n = 624) in the ASCEND (Study 016; NCT01366209) and CAPACITY (Studies 004 and 006; NCT00287716 and NCT00287729) phase III trials were included in this post hoc analysis. Read More

View Article
November 2018
1 Read

Multimodal remote monitoring of high cardiovascular risk OSA patients initiating CPAP: a randomized trial.

Chest 2018 Nov 22. Epub 2018 Nov 22.

HP2 laboratory, INSERM U1042, Grenoble Alpes University, Grenoble, France; EFCR laboratory, Pole Thorax and Vessels, Grenoble Alps University Hospital, Grenoble, France.

Background: The management of patients with high cardiovascular risk and obstructive sleep apnea (OSA) must target not only improving adherence to continuous positive airway pressure (CPAP) but should also include strategies aimed at reducing blood pressure (BP) and increasing physical activity. The study aims to evaluate the effectiveness of an integrated intervention using remote patient telemonitoring in reducing BP in high cardiovascular risk OSA patients.

Methods: In a multicenter, open, randomized trial, OSA patients were randomly assigned at CPAP initiation to usual care or multimodal telemonitoring for 6 months. Read More

View Article
November 2018
5 Reads

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Hypertrophic Cardiomyopathy: A Nationwide Cohort Study.

Chest 2018 Nov 22. Epub 2018 Nov 22.

Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; Institute of Cardiovascular Science, University of Birmingham, United Kingdom; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; and Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. Electronic address:

Background: Chronic anticoagulation is recommended in patients with hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF). Non-vitamin K antagonist oral anticoagulants (NOACs) are an alternative to warfarin, but there are limited data to support their use in patients with HCM and AF. We sought to compare thromboembolic events, bleeding, and mortality between NOAC and warfarin in patients with HCM and AF. Read More

View Article
November 2018
6 Reads

Solriamfetol for the treatment of excessive sleepiness in obstructive sleep apnea: A placebo-controlled randomized-withdrawal study.

Chest 2018 Nov 21. Epub 2018 Nov 21.

Brigham and Women's Hospital and Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Background: Excessive sleepiness is a common symptom of obstructive sleep apnea (OSA), which often persists despite primary OSA therapy. This phase 3 randomized-withdrawal trial evaluated solriamfetol (JZP-110) for the treatment of excessive sleepiness in adults with OSA.

Methods: After 2 weeks of clinical titration (n=174) and 2 weeks of stable dosing (n=148), participants who reported improvement on the Patient Global Impression of Change (PGI-C) and had numerical improvements on the Maintenance of Wakefulness Test (MWT) and Epworth Sleepiness Scale (ESS) were randomized to placebo (n=62) or solriamfetol (n=62) for 2 additional weeks; 13. Read More

View Article
November 2018
2 Reads

Effect of Combined β-Lactam / Macrolide Therapy on Mortality According to the Microbial Aetiology and Inflammatory Status of Patients with Community - Acquired Pneumonia.

Chest 2018 Nov 21. Epub 2018 Nov 21.

Pneumology Department, Respiratory Institute (ICR), Hospital Clinic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) - University of Barcelona (UB), SGR 911 - Ciber de Enfermedades Respiratorias (CIBERES), ICREA Academia, Villarroel 170 (08036) Barcelona, Spain. Electronic address:

Background: Antibiotic combinations that include macrolides have shown lower mortality rates than β-lactams in monotherapy or combined with fluoroquinolones in patients with community-acquired pneumonia (CAP). However, this effect has not been studied according to the levels of C-reactive protein (CRP) in CAP with identified microbial cause.

Objectives: In patients with CAP and known microbial cause we aimed to evaluate 30 day mortality of a β-lactam plus macrolide (BL+M) compared to a fluoroquinolone alone with or without a β-lactam (FQ±BL) METHODS: We analysed a prospective observational cohort of patients with CAP admitted to Hospital Clinic of Barcelona between 1996 to 2016. Read More

View Article
November 2018
1 Read

Accuracy of algorithms to identify pulmonary arterial hypertension in administrative data: a systematic review.

Chest 2018 Nov 21. Epub 2018 Nov 21.

Center for Healthcare Organization & Implementation Research, Edith Nourse Rogers Veterans Hospital The Pulmonary Center, Boston University School of Medicine.

Background: The diagnosis of pulmonary arterial hypertension (PAH) is challenging, and there is significant overlap with the more heterogenous diagnosis of pulmonary hypertension (PH). Clinical and research efforts that rely on administrative data are limited by current coding systems that do not adequately reflect the clinical classification scheme. The aim of this systematic review is to investigate current algorithms to detect PAH using administrative data and to appraise the diagnostic accuracy of these algorithms against a reference standard. Read More

View Article
November 2018
2 Reads

The Cost-effectiveness of Corticosteroids for the treatment of Community-Acquired Pneumonia.

Chest 2018 Nov 15. Epub 2018 Nov 15.

Infectious Diseases Division, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, Rhode Island, United States of America. Electronic address:

Background: The use of corticosteroids as adjunct treatment for community-acquired pneumonia (CAP) is associated with potential clinical benefits and the aim of this study was to evaluate the cost-effectiveness of this approach.

Methods: We constructed a decision-analytic model comparing the use of corticosteroids+antibiotics to that of placebo+antibiotics for the treatment of CAP. Cost-effectiveness was determined by calculating deaths averted and incremental cost-effectiveness ratios (ICER). Read More

View Article
November 2018
1 Read

Air Pollution and Non-Communicable Diseases: A review by the Forum of International Respiratory Societies' Environmental Committee. Part 2: Air pollution and organ systems.

Chest 2018 Nov 9. Epub 2018 Nov 9.

School of Earth, Society, and Environment, Department of Atmospheric Sciences, University of Illinois, Urbana, IL, USA.

Although air pollution is well-known to be harmful to the lung and airways, it can also damage most other organ systems of the body. It is estimated that about 500,000 lung cancer deaths and 1.6 million chronic obstructive pulmonary disease (COPD) deaths can be attributed to air pollution, but air pollution may also account for 19% of all cardiovascular deaths and 21% of all stroke deaths. Read More

View Article
November 2018
6 Reads

The Landscape of US Lung Cancer Screening Services.

Chest 2018 Nov 9. Epub 2018 Nov 9.

Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address:

Background: Low adoption of lung cancer screening is potentially caused by inadequate access to a comprehensive lung cancer screening registry (LCSR), currently a requirement for reimbursement by the Centers for Medicare and Medicaid Services. However, variations in LCSR facilities have not been extensively studied.

Methods: We applied a hierarchical clustering method to a comprehensive database integrating state-level LCSR facility density, defined as the number of facilities per 100,000 at-risk persons, lung cancer outcomes including mortality and stage-specific incidence, and socioeconomic and behavioral factors. Read More

View Article
November 2018
4 Reads

Air Pollution and Non-Communicable Diseases: A Review by the Forum of International Respiratory Societies' Environmental Committee, Part 1: The damaging effects of air pollution.

Chest 2018 Nov 9. Epub 2018 Nov 9.

School of Earth, Society, and Environment, Department of Atmospheric Sciences, University of Illinois, Urbana, IL, USA.

Air pollution poses a great environmental risk to health. Outdoor fine particulate matter (PM) exposure is the fifth leading risk factor for death in the world, accounting for 4.2 million deaths and more than a hundred million disability-adjusted-life-years lost according to the Global Burden of Disease Report. Read More

View Article
November 2018
7 Reads

Charge Reductions Associated With Shorter Time to Recovery in Septic Shock.

Chest 2018 Nov 9. Epub 2018 Nov 9.

Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN.

Background: Septic shock therapies that shorten the time to physiologic and clinical recovery may result in financial savings. However, the financial implications of improving these nonmortal outcomes are not well characterized. Therefore, we quantified hospital charges associated with four outcomes: ICU length of stay, duration of invasive mechanical ventilation, duration of vasopressor use, and new renal replacement therapy. Read More

View Article
November 2018
8 Reads

Trends in Hospitalization and In-Hospital Mortality from Venous Thromboembolism, 2007 to 2016, in China.

Chest 2018 Nov 9. Epub 2018 Nov 9.

Graduate School of Peking Union Medical College, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China; National Clinical Research Center for Respiratory Diseases, Beijing, China. Electronic address:

Background: Venous thromboembolism (VTE) has emerged as a major public health problem. However, data on VTE burden in China is seldom reported.

Methods: We collected data on patients with principal diagnose of VTE, pulmonary embolism (PE), or deep vein thrombosis (DVT) using the International Classification of Diseases, 10th Revision (ICD-10) from 90 hospitals across China. Read More

View Article
November 2018
1 Read

Epigenetic Changes in Airway Smooth Muscle as a Driver of Airway Inflammation and Remodeling in Asthma.

Chest 2018 Nov 8. Epub 2018 Nov 8.

Division of Respiratory Medicine, Nottingham University Hospitals NHS Trust (City Hospital Campus); and the Nottingham NIHR Biomedical Research Centre, Nottingham MRC Molecular Pathology Node. Electronic address:

Epigenetic changes are heritable changes in gene expression, without changing the DNA sequence. Epigenetic processes provide a critical link between environmental insults to the airway and functional changes that determine how airway cells respond to future stimuli. There are three primary epigenetic processes: histone modifications, DNA modification, and noncoding RNAs. Read More

View Article
November 2018

Mandibular Movement Analysis to Assess Efficacy of Oral Appliance Therapy in OSA.

Chest 2018 Dec 6;154(6):1340-1347. Epub 2018 Nov 6.

HP2 INSERM U1042, Université Grenoble Alpes, Saint-Martin-d'Hères, France.

Rationale: The respiratory effort index derived from vertical mandibular movements (MM-REI) is a potential marker of increased respiratory effort during sleep. We evaluated the effectiveness of mandibular advancement splint therapy using MM-REI, in comparison with the apnea-hypopnea index (AHI) and oxygen desaturation index (ODI).

Methods: Fifty-six subjects (median age, 47 years) with OSA treated with a custom mandibular advancement splint (Herbst appliance) were evaluated at the end of the titration procedure when snoring was reported absent by the sleep partner. Read More

View Article
December 2018
1 Read

A 32-Year-Old Man With HIV Infection, Pleural Effusions, and Lymphadenopathy.

Chest 2018 Nov;154(5):e147-e151

Divisions of Critical Care, Pulmonary and Sleep Medicine, Department of Internal Medicine, The University of Texas Health Science Center at Houston-McGovern Medical School, Houston, TX.

Case Presentation: A 32-year-old man presented with fever, nonproductive cough, diffuse lymphadenopathy, and polyarticular pain for 2 weeks. His medical history included HIV diagnosed 10 years ago, anal intraepithelial neoplasia, Kaposi sarcoma, and herpes simplex virus-2 infection. The patient was not receiving antiretroviral therapy or antibiotic prophylaxis, and his last known CD4 count a month before was 45 cells/mm. Read More

View Article
November 2018
5 Reads

A 40-Year-Old Man With Albinism and Progressive Dyspnea.

Chest 2018 Nov;154(5):e143-e146

Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN.

Case Presentation: A 40-year-old male subject employed as a grocery store manager presented to a pulmonary clinic with a dry cough and progressive dyspnea of 1 year duration. The patient was previously an avid cyclist and first noted his dyspnea when he was unable to bike as far as before. Bilateral interstitial lung infiltrates were recently noted on chest radiography. Read More

View Article
November 2018
2 Reads

A 48-Year-Old Athletic Man With Bradycardia During Sleep.

Chest 2018 Nov;154(5):e139-e142

Sleep Disorders Center, Neurologic Institute, Cleveland Clinic, Cleveland, OH.

Case Presentation: A 48-year-old athletic man with history of dyslipidemia and second-degree atrioventricular block (Mobitz type I 2:1 atrioventricular block) endorses sleep-related difficulties at his annual physical examination. Mobitz type I block was diagnosed 11 years earlier when the patient presented to his primary care physician with left-sided chest pain for 2 months. He was evaluated by cardiology, with a normal stress echocardiogram. Read More

View Article
November 2018
5 Reads

An 80-Year-Old Man With Hemoptysis and Unilateral Patchy Opacities.

Chest 2018 Nov;154(5):e135-e138

4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.

Case Presentation: An 80-year-old man presented with a 5-day history of hemoptysis, mild shortness of breath on exertion, fatigue, and malaise. He denied chest pain or fever. He had a history of hypertension, congestive heart failure, and left nephrectomy for renal cancer 10 years earlier; he was a former cigarette smoker with a 50 pack-year history, having quit 5 years prior to presentation. Read More

View Article
November 2018
11 Reads

A 67-Year-Old Man With Psoriatic Arthritis and New-Onset Dyspnea.

Chest 2018 Nov;154(5):e127-e134

Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore; University Medicine Cluster, Division of Respiratory and Critical Care Medicine, National University Hospital, National University Health System, Singapore. Electronic address:

A 67-year-old retired air force officer presented with a 6-month history of nonproductive cough, progressive exertional dyspnea, and weight loss. He was unable to walk beyond 100 m compared with his baseline of unlimited walking distance. He denied fever, hemoptysis, myalgia, or chest pain. Read More

View Article
November 2018
2 Reads

A 54-Year-Old Woman With Chest Pain and Shortness of Breath.

Chest 2018 Nov;154(5):e123-e125

Pulmonary and Critical Care Medicine, Stony Brook University Hospital, Stony Brook, NY. Electronic address:

View Article
November 2018
3 Reads

A Young Man With Abdominal Pain, Shock, and Respiratory Distress.

Chest 2018 Nov;154(5):e119-e121

Mount Sinai St. Luke's and Mount Sinai West; Icahn School of Medicine at Mount Sinai, New York, NY.

View Article
November 2018
2 Reads